Abstract.
Ataxia telangiectasia and Rad3-related (ATR), a kinase that regulates a DNA damage response pathway, is mutated in ATR-Seckel Syndrome (ATR-SS), a disorder characterised by severe microcephaly and growth delay. Impaired ATR-signalling is also observed in cell lines from additional disorders characterised by microcephaly and growth delay, including non-ATR SS, Nijmegen Breakage Syndrome and MCPH1-dependent Primary Microcephaly. Here, we examined ATR-pathway function in cell lines from three haploinsufficient contiguous gene deletion disorders, a subset of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Miller-Dieker Lissencephaly Syndrome and Williams-Beuren Syndrome, in which the deleted region encompasses ATR, RPA1 or RFC2 respectively. These three genes function in ATR-signalling. Cell lines from these disorders displayed an impaired ATRdependent DNA damage response. Thus, we describe ATR-signalling as a pathway unusually sensitive to haploinsufficiency and identify three further human disorders displaying a defective ATR-dependent DNA damage response. The striking correlation of ATR-pathway dysfunction with the presence of microcephaly and growth delay strongly suggests a causal relationship.
Introduction.
Ataxia telangiectasia and Rad3-related (ATR) protein is a central component of a DNA damage response signalling pathway 1, 2 . ATR (MIM601215) is mutated in two families displaying Seckel Syndrome (SS) (MIM 210600), a disorder characterised by severe microcephaly, proportionate dwarfism and dysmorphic facial features [3] [4] [5] . SS is clinically and genetically heterogeneous 6 . Significantly, cell lines derived from additional SS patients, although not harbouring mutations in ATR, display ATRsignalling defects 6 . Thus, SS can be attributed to defects in ATR-signalling with a sub-set of patients, designated ATR-SS, having mutations in ATR itself. Additionally, three other disorders characterised by microcephaly and growth delay, Nijmegen
Breakage Syndrome (MIM251260), Fanconi anaemia (MIM227650) and MCPH1-defective Primary Microcephaly (MIM251200), display impaired ATR-signalling responses 7, 8 . Together, these findings suggest that impaired ATR signalling can impact upon development conferring microcephaly and growth delay.
ATR is a phosphoinositol 3-kinase-like kinase (PIKK) that is activated by single stranded (ss) regions of DNA generated following replication fork stalling or during the repair of bulky lesions 9 . ATR interacts with ATRIP (ATR-interacting protein) and is recruited to ssDNA regions, in part by ATRIP's ability to bind to Replication Protein A (RPA), a complex of three subunits, Rpa1-3 [9] [10] [11] . The Rad17/Rfc2-5 complex, together with a complex involving Rad9, Rad1 and Hus1, also functions to enhance ATR-signalling either by impacting upon ATR recruitment or activation 12 . Thus, these additional proteins are required for the ATR-signalling response and therefore represent potential candidate genetic defects for SS 6 . Hence, defects in these genes may confer 'Seckel-like' clinical features. 24 . RF-C loads proliferating cell nuclear antigen (PCNA) onto chromatin during DNA replication and four of its five subunits, Rfc2-5, form a complex with Rad17 that functions in ATR-signalling 11, [25] [26] [27] .
The association of severe microcephaly and growth retardation with heterozygous loss of genes encoding proteins involved in the ATR-signalling pathway, prompted us to examine whether haploinsufficiency for these genes might impact upon the ATR-signalling response. We, therefore, examined cell lines obtained from these contiguous gene disorders for their ability to effect the ATRdependent DNA damage response. We employed sensitive assays capable of detecting 6 defective ATR-pathway function that we had previously established to examine SS cell lines. Strikingly, we observed defects in ATR-signalling in all three disorders demonstrating that ATR-signalling is sensitive to haploinsufficiency.
Materials and methods

Cell lines.
Lymphoblastoid cell lines (LBLs) were cultured in RPMI 1640 with 15% foetal calf serum. GM02188 (wild type, WT) and DK0064 (ATR-SS) have been described 
Western blotting and Chromatin extraction.
Western blotting was carried out as described previously 8 . For γ-H2AX analysis, a chromatin extraction step was included. Briefly, 1x10 7 cells were washed once in PBS and re-suspended in 100 µl hypotonic buffer (10mM HEPES pH 7.5, 5mM KCl, 1.5mM MgCl 2 , 1mM DTT, 10mM NaF, 1mM Na 2 VO 3 , 10mM β-glycerolphosphate, 0.5% IPEGAL and Protease Inhibitor Cocktail from Sigma, Poole, UK). Lysates were incubated on ice for 15 mins, pelleted and washed twice (200 l each) in hypotonic buffer. The pellet was treated with hypertonic buffer (hypotonic buffer with 0.5M 8 NaCl) and incubated on ice for 15mins. Following washing in hypertonic buffer, the chromatin pellets were re-suspended in 100 µl of SDS-PAGE loading buffer (with 5% SDS, 10% β-mercaptoethanol) and sonicated. 10 µl of the chromatin fraction was separated on 17% SDS-PAGE.
G2/M checkpoint arrest.
Cells were irradiated with 5 J/m 2 UV-C and immediately seeded into complete medium with 1.5 M nocodazole and incubated for 24 hrs before being cytospun onto poly-D-lysine coated slides and processed for immunofluorescence with α-pS10-Histone H3 and counterstaining with DAPI.
Nuclear fragmentation.
Cells were treated with 5 mM HU in the presence of 1.5 M nocodazole for 24 hrs and processed as described previously 6 .
Transfection.
x 10
5 cells/ml in 3 mls were transiently transfected with 2 g of pcDNA3-ATR, pcDNA3.1-RPA1 or pcDNA3.1-RFC2 using Genejuice (Novagen), according to the manufacturers instructions, and incubated for 24 hrs prior to nuclear fragmentation processing. For complementation of the G2/M checkpoint, cells were incubated for 24 hrs and re-transfected for a further 24 hrs before processing.
RNAi transfection.
The control wild type LBL GM02188 was used for siRNA experiments. Cells were transfected once with 10 nM of respective siRNA duplex using SiPort TM NeoFX TM transfection reagent according to the manufacturers instructions (Ambion, Huntington, UK). Oligonucleotides (sense) used were ATR 5'-AAC CUC CGU GAU GUU GCU UGA -3', RPA1 5'-AAA CCA UCC ACG AAG CUU AUA GGC C -3', 9
Lis1 5'-UUG AUU UGG CCG UAC CAU ACG UAC C-3' and a control oligo directed to GFP 5'-AAC ACU UGU CAC UAC UUU CTC.
Results.
ATR-signalling is impaired in a BPES cell line haploinsufficient for ATR.
A previous study reported heterozygosity for ATR due to an interstitial deletion on 3q in a boy with BPES who displayed non-BPES clinical features that included mental retardation, microcephaly and growth delay 18 . A representation of the deletion is shown in Fig 1A. We obtained a lymphoblastoid cell line (LBL) derived from this patient and by immunoblotting observed approximately two fold reduced ATR protein levels compared to a control LBL (ATR-BPES+/- Fig 1B) . The level of ATRIP was also reduced approximately two fold, consistent with reports that ATR and ATRIP are co-regulated 10 . Nbs1 served as a loading control and was expressed at similar levels in both lines ( Fig 1B) . An early step in the DNA damage response regulated by ATR is phosphorylation of the histone H2A variant, H2AX on serine 139 (termed γH2AX), which can be detected by immunoblotting of chromatin bound proteins using α-γH2AX antibodies 28 . Following exposure to hydroxyurea (HU), an agent that causes replication fork stalling, a strong γH2AX signal was observed in control LBLs indicating activation of ATR-dependent damage response signalling. However, in marked contrast, detectable γH2AX was not observed in the ATR-SS LBLs, nor in LBLs derived from the BPES-ATR+/-patient ( Fig 1C) . Chk1 represents an important phosphorylation target of ATR that is required for the stability of arrested replication forks and cell cycle arrest [29] [30] [31] [32] [33] . HU-induced phosphorylation of Chk1 on serine 317, a known ATR target site, was also significantly diminished in LBLs from the BPES-ATR+/-patient, similar to ATR-SS LBLs (Fig 1D) 6 . An important end point of ATR activation regulated by Chk1 is onset of G2/M checkpoint arrest, which serves to prevent cells harbouring DNA damage from entering mitosis 6 . To monitor G2/M checkpoint arrest, the percentage of mitotic cells was examined in untreated cells or Con-MR, which has a heterozygous telomeric deletion that does not involve either RPA1 or Lis1, was derived from a mildly mentally retarded patient (Fig 2B) . This Fig 2B) . Next we examined HU-induced γH2AX formation in representative LBLs either haploinsufficient for RPA1 or with both copies of the gene.
Impaired HU-induced γH2AX was observed in the ATR-SS, ILS+ A and MDLS A LBLs, the latter two of which exhibit haploinsufficiency for RPA1 (Fig 2B & Fig 2D) .
Normal HU-induced γH2AX was observed in wild type control LBLs (WT) and in those cell lines where the deletion that did not encompass RPA1 (Con-MR, ILS A, ILS B) (Fig 2B & Fig 2D) . Similarly, MDLS A LBLs also exhibited impaired HU-induced Chk1-pSer317 formation, unlike Con-MR and ILS A LBLs (Fig 2E) . We also examined the ability to activate UV-induced G2/M checkpoint arrest and observed impaired arrest specifically in the seven LBLs with haploinsufficiency for RPA1 ( Fig   3A & Fig 2B) . Furthermore, we examined HU-induced NF and observed elevated levels specifically in those LBLs from patient's haploinsufficient for RPA1 (Fig 3B &   Fig 2B) .
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To verify that the G2/M checkpoint and NF phenotypes were a consequence of haploinsufficiency for RPA1, these damage response phenotypes were examined following transfection of two MDLS LBLs (MDLS A and MDLS C) with RPA1
cDNA. Expression of RPA1 cDNA resulted in recovery of G2/M checkpoint arrest and a diminished number of cells displaying HU-induced NF in both LBLs (Fig 3C &   D) .
Mildly decreased expression of RPA1 and ATR but not Lis1 using siRNA affects ATR-pathway function following DNA damage.
As an alternative way to determine whether the ATR-dependent DNA damage response might be sensitive to small perturbations in ATR or Rpa1 expression, we utilised a single round of transfection with a low concentration (10nM) of siRNA oligonucleotides to mildly reduce the expression of Lis1, Rpa1 and ATR in the control LBLs. We obtained an approximately two-fold reduction in Lis1, Rpa1 and ATR expression in control LBLs (Fig 4A) . This reduction in Rpa1 and ATR protein levels conferred a failure to activate G2/M checkpoint arrest following UV-irradiation (Fig 4B) . In contrast, the clearly observable reduction in Lis1 expression following siRNA did not impact upon UV-induced G2/M checkpoint arrest (Fig 4B) . Similarly, mild siRNA mediated reduction in the expression of ATR and Rpa1 caused elevated levels of NF after HU treatment, which was not observed following siRNA using oligonucleotides directed against Lis1 or GFP (Fig 4C) .
These results provide strong evidence suggesting that even a mild decrease in protein levels of either ATR or Rpa1 impacts upon the ability of cells to mount a normal ATR-signalling response following exposure to DNA damage.
Impaired ATR-dependent DNA damage response signalling in Williams-Beuren
Syndrome: correlation with haploinsufficiency for RFC2.
The heterozygous interstitial deletion on chromosome 7q11.23 seen in WBS is shown in Fig 5A. The deletion encompasses multiple genes including RFC2, a subunit of the Rad17/Rfc2-5 complex that plays a role in the ATR-dependent pathway (Fig 5B) . Fig   5B also shows the microdeletion observed in a typical SVAS patient that does not encompass RFC2 but includes ELN. Whilst a hypomorphic mutation in
Saccharomyces cereviaiae RFC2 (rfc2-1) has been shown to impair normal cell cycle checkpoint activation, a direct demonstration of a similar response in humans cells has not been described 34 . To examine whether haploinsufficiency for RFC2 might cause impaired ATR-dependent damage response, we examined two WBS LBLs
(WBS-I & WBS-II) and LBLs derived from one respective clinically normal parent (WT-I & WT-II).
Significantly, defective HU-induced Chk1-pSer317 formation was also seen in WBS LBLs (WBS-I and WBS-II), compared to their respective clinically normal parental LBLs (WT-I and WT-II) (Fig 5C) . Correspondingly, both WBS LBLs failed to induce any significant G2/M checkpoint arrest following exposure to UV in contrast to the efficient checkpoint arrest observed in both parent lines (Fig 5D) .
Additionally, both WBS LBLs but neither parental line showed induction of NF after exposure to HU (Fig 5E) . Elevated levels of G2/M checkpoint arrest (Fig 5F) and reduced HU-induced NF ( Fig 5G) were observed in both WBS LBLs following transfection with RFC2 cDNA. Together, these data provide strong evidence that haploinsufficiency for RFC2 also confers an impaired ATR-dependent signalling response.
Discussion
Here, we examined cell lines derived from patients with BPES-ATR+/-, MDLS and WBS, three distinct contiguous gene deletion disorders exhibiting microcephaly and growth delay. In all cases, the heterozygous genomic deletions encompass a gene that is critical for the ATR-signalling response, namely ATR itself (BPES-ATR+/-), RPA1
(MDLS) or RFC2 (WBS). Patient-derived cell lines haploinsufficient for any of these genes displayed an impaired response to DNA damage using assays that have been selected to identify defective ATR-signalling. Indeed, the defect was similar to that displayed by an SS cell line with a homozgyous, hypomorphic mutation in ATR (ATR-SS) 3, 6 . Our findings, therefore, provide strong evidence that haploinsufficiency for ATR as well as additional components of the ATR-dependent signalling pathway, confers an impaired ability to respond to DNA damage or replication fork stalling.
Our assays were established to identify ATR-signalling defects in SS and employ relatively modest DNA damaging treatments to allow the detection of potentially hypomorphic mutations 3, 6 . Indeed, we have observed that following more dramatic treatments (eg. high UV doses), the defect in ATR-SS cells is overridden, presumably due to the induction of a sufficient damage response signal by the residual protein 3 .
This is distinct to other DNA damage response assays where high doses are often utilised to overload the pathway and expose a repair defect 35 . Although our assays are optimised to detect a subtle deficiency and may not completely reflect the role of ATR during development, they represent modest treatments that may not be entirely distinct to those occurring during cellular growth and development. Thus, the impact of haploinsufficiency appears to represent a unique phenotype of ATR-signalling in contrast to other DNA damage response pathways.
Impaired ATR-signalling is associated with microcephaly and growth delay in humans 3, 7, 8, 36 . The correlation of microcephaly, growth delay and impaired ATRpathway dysfunction in the haploinsufficiency disorders presented here provides further evidence suggestive of a causal relationship. Since ATR-SS is a recessive disorder, ATR-haploinsufficiency alone is unlikely to confer a clinical phenotype.
Rather, the clinical features observed in these haploinsufficiency disorders are probably a consequence of combined haploinsufficiency for ATR-signalling genes and additional genes that may impact upon neuronal development and cell proliferation. Indeed combined heterozygosity of Lis1 and 14-3-3ε has been shown to influence the severe clinical features in MDLS 37 . Human brain size has increased dramatically during evolution requiring enormous and rapid proliferation from a small number of precursor stem cells 38 . Moreover, developing neurons incur high levels of oxidative DNA damage placing a significant load on the damage response pathways.
Thus, the developing brain may have a high requirement for the ATR-signalling pathway necessitating a diploid content of component proteins, particularly if further stress is imposed by haploinsufficiency of other genes. Mice, as models for haploinsufficiency disorders have been used to investigate neuronal migration but may be limited in their application concerning microcephaly due to the relatively smaller size of murine brains compared to humans 39, 40 .
Finally, it should be noted that defective ATR-pathway function has not previously been described in any of the contiguous gene deletion disorders investigated here (BPES-ATR+/-, MDLS and WBS). Since increased life expectancy due to improved medical supervision is now a feature of conditions such as MDLS, a defective DNA damage response in this context may be relevant to potential tumour development 41 . Furthermore, a defective DNA damage response can adversely affect treatment of malignancy by standard chemotherapeutic or bone marrow transplantation regimens 42, 43 . It is unclear whether any of the conditions investigated here are tumour predisposition conditions, although isolated reports of malignancy in MDLS and particularly WBS patients exist 41, [44] [45] [46] . Interestingly, hypomorphic mutations in RFC subunits are associated with genetic instability in yeast and a heterozygous missence mutation in Rpa1 results in increased levels of lymphoid malignancy in mice 34, 47, 48 . Defective ATR function has been described in various cancer-types [49] [50] [51] . Furthermore, it has been suggested that ATR may act as a tumour suppressor, when haploinsufficient, under certain circumstances 52 .
A recent study reported that copy number variation of DNA sequences is a common genomic trait 53 . Understanding the impact of haploinsufficiency is likely to be important to assess inter-individual genetic variation as well as the basis underlying haploinsufficiency disorders. In conclusion, we identify ATR-signalling as Reduced expression of ATR and ATRIP is seen in BPES-ATR+/-cells specifically.
Nbs1 served as a loading control and was expressed at normal levels. 
